Cargando…
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies
Cancer immunotherapy has emerged as a novel cancer treatment, although recent immunotherapy trials have produced suboptimal outcomes, with durable responses seen only in a small number of patients. The tumor microenvironment (TME) has been shown to be responsible for tumor immune escape and therapy...
Autores principales: | Kumari, Nisha, Choi, Seung Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857848/ https://www.ncbi.nlm.nih.gov/pubmed/35183252 http://dx.doi.org/10.1186/s13046-022-02272-x |
Ejemplares similares
-
Advances in technology and applications of nanoimmunotherapy for cancer
por: Dou, Lei, et al.
Publicado: (2021) -
Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma
por: Luo, Hong, et al.
Publicado: (2023) -
Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates
por: Lameijer, Marnix, et al.
Publicado: (2018) -
New Mechanisms of Tumor-Associated Macrophages on Promoting Tumor Progression: Recent Research Advances and Potential Targets for Tumor Immunotherapy
por: Guo, Qiujun, et al.
Publicado: (2016) -
Recent advances in nanomedicines for regulation of macrophages in wound healing
por: Joorabloo, Alireza, et al.
Publicado: (2022)